-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pregnant women do not appear to be more susceptible to SARS-CoV-2 infection than non-pregnant women, but they are at higher risk for severe COVID -19 disease
.
Compared with non-pregnant women of reproductive age, pregnant women infected with SARS-CoV-2 were more likely to be admitted to the intensive care unit, receive invasive ventilation and extracorporeal membrane oxygenation
Infection with COVID-19 Prevention
In a study published in the top medical journal Nature Medicine, researchers used population-wide data from a national prospective cohort to describe COVID-19 vaccination and SARS-CoV-2 infection among pregnant women in Scotland
.
Between 8 December 2020 and 31 October 2021 when the COVID-19 vaccination was launched in Scotland, researchers administered 25,917 doses of the COVID-19 vaccine to 18,457 pregnant women
.
Pregnant women have significantly lower vaccination rates than non-pregnant women aged 18-44
32.
3% of women who gave birth in October 2021 received two doses of the vaccine, compared with 77.
4% of all women
.
Perinatal mortality prolongation for women who delivered within 28 days of COVID-19 diagnosis was 22.
diagnosis
Thus, addressing the low vaccination rates of pregnant women is critical to protecting the health of women and infants during the ongoing COVID-19 pandemic
.
.
Original source:
Original source:Sarah J.
